1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co. Ltd.
  6. News
  7. Summary
    1099   CNE100000FN7

SINOPHARM GROUP CO. LTD.

(1099)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-08-17 am EDT
16.92 HKD   -2.76%
08/09SY Holdings Bags $6 Million Contract to Supply Sinopharm-Affiliated Hospitals with Software Systems
MT
07/08Sinopharm Mulls $1 Billion Purchase of DNA Products Supplier BBI Life Sciences
MT
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sinopharm Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021, Payable No Later Than 23 August 2022

06/23/2022 | 10:48am EDT

Sinopharm Group Co. Ltd. announced that the declaration and payment of Ordinary final dividend of RMB 0.75 per share (inclusive of tax) for the year ended 31 December 2021 (the "Final Dividend") was approved at the AGM. The Final Dividend will be paid no later than 23 August 2022 to the Shareholders whose names appear on the register of members of the Company on 4 July 2022. Ex-dividend date is 27 June 2022.


© S&P Capital IQ 2022
All news about SINOPHARM GROUP CO. LTD.
08/09SY Holdings Bags $6 Million Contract to Supply Sinopharm-Affiliated Hospitals with Soft..
MT
07/08Sinopharm Mulls $1 Billion Purchase of DNA Products Supplier BBI Life Sciences
MT
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
06/23Sinopharm Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021, ..
CI
06/21Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
06/17Sinopharm Group Co. Ltd. Announces Executive Changes
CI
06/10Sinopharm Group Co. Ltd. Announces Resignation of Deng Jindong as Member of Audit Commi..
CI
06/10ChromaDex Signs Tru Niagen Distribution Deal With Sinopharm Xingsha; Shares Climb Prema..
MT
06/02Sinopharm Group Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, ..
CI
05/19CanSino Biologics Rises After WHO Approves Covid Vaccine for Emergency Use
DJ
More news
Analyst Recommendations on SINOPHARM GROUP CO. LTD.
More recommendations
Financials
Sales 2022 576 B 84 983 M 84 983 M
Net income 2022 8 545 M 1 260 M 1 260 M
Net Debt 2022 22 148 M 3 266 M 3 266 M
P/E ratio 2022 5,33x
Yield 2022 5,60%
Capitalization 45 650 M 6 732 M 6 732 M
EV / Sales 2022 0,12x
EV / Sales 2023 0,11x
Nbr of Employees 113 234
Free-Float 43,0%
Chart SINOPHARM GROUP CO. LTD.
Duration : Period :
Sinopharm Group Co. Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO. LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 14,63 CNY
Average target price 20,28 CNY
Spread / Average Target 38,6%
EPS Revisions
Managers and Directors
Yong Liu President & Executive Director
Xiao Juan Li Chief Financial Officer
Fang Yao Chairman-Supervisory Board
Qing Ming Yu Chairman
Wu Ping Tao Member-Supervisory Board
Sector and Competitors